Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00076 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Sophie R Cohen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Neurobiology & Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania 19129, United States. Hauptthemen laut MEDLINE: Receptors, Dopamine D3, Dopamine Plasma Membrane Transport Proteins, Cocaine, Dopamine Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Cocaine use disorder is a major healthcare issue with no effective FDA-approved treatments. Cocaine exerts its effects - in part - by blocking dopamine transporters (DAT) and subsequently dysregulating DAT function. Several molecular targets have been identified as key regulators of DAT function and expression including dopamine D3 receptors (D3R) that are highly expressed in the mesolimbic dopamine pathway. Although D3R partial agonists and antagonists have been shown to influence cocaine seeking in rodents, effects have been inconsistent with studies reporting varying outcomes on cocaine-associated behavior. In this study, we tested the effects of SK609, a novel G-protein biased D3R agonist, and pramipexole, an unbiased agonist of D3R, on DAT expression and function and cocaine-seeking behavior. Results indicated that SK609 reduced phosphorylation of DATs following cocaine and the uptake inhibition effects of cocaine on dopamine transmission in in vitro and ex vivo studies, respectively. By comparison, pramipexole augmented the effects of cocaine on DAT phosphorylation, enhanced dopamine levels, and increased cocaine seeking in rats. These results suggest that unbiased D3R activation promotes the effects of cocaine and that limiting D3R agonists to G-protein signaling pathways may have the potential to reduce these effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dept. of Neurobiology & Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania 19129, United States.
- Dept. of Microbiology & Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19129, United States.
ORCID-Profile: Sandhya Kortagere
Förderung
- NIDA NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute on Drug Abuse
Zitieren
APA
Cohen, S. R., Xu, W., Aziz, N. F., España, R. A., & Kortagere, S. (2025). Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00076
Vancouver
Cohen SR, Xu W, Aziz NF, España RA, Kortagere S. Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00076
BibTeX
@article{Cohen2025,
author = {Cohen, Sophie R and Xu, Wei and Aziz, Nastaran F and España, Rodrigo A and Kortagere, Sandhya},
title = {Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00076}
}
EUVIMED